NASH limits anti-tumour surveillance in immunotherapy-treated HCC
Project: FAITH
Updated at: 27-04-2024
Project: FAITH
Updated at: 27-04-2024
Project: FAITH
Updated at: 27-04-2024
Project: FAITH
Updated at: 27-04-2024
Project: FAITH
Updated at: 27-04-2024
Project: FAITH
Updated at: 27-04-2024